HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47012,
"recordsTotal": 47012,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=completion_date&start=41700",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=completion_date&start=41100",
"results": [
{
"registry_id": "NCT03839771",
"publication_url": "https://clinicaltrials.gov/study/NCT03839771",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy.",
"has_exemption": false,
"start_date": "2019-03-01",
"completion_date": "2027-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting Hemato-Oncologie voor Volwassenen Nederland",
"sponsor_slug": "stichting-hemato-oncologie-voor-volwassenen-nederland",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06090903",
"publication_url": "https://clinicaltrials.gov/study/NCT06090903",
"title": "Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2027-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06427395",
"publication_url": "https://clinicaltrials.gov/study/NCT06427395",
"title": "A Multicenter, Open-Label, Extension Clinical Trial to Evaluate Safety and Efficacy of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2027-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05774951",
"publication_url": "https://clinicaltrials.gov/study/NCT05774951",
"title": "CAMBRIA-1: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Without Disease Recurrence",
"has_exemption": false,
"start_date": "2023-03-31",
"completion_date": "2027-04-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029711",
"publication_url": "https://clinicaltrials.gov/study/NCT07029711",
"title": "A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RITLECITINIB IN PEDIATRIC PARTICIPANTS 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2027-04-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04031677",
"publication_url": "https://clinicaltrials.gov/study/NCT04031677",
"title": "A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk RetroPeritoneal Sarcoma (RPS)",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2027-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "European Organisation for Research and Treatment of Cancer - EORTC",
"sponsor_slug": "european-organisation-for-research-and-treatment-of-cancer-eortc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06647407",
"publication_url": "https://clinicaltrials.gov/study/NCT06647407",
"title": "A Parallel-group Prevention, Phase II, Partially Blinded, Multi-stage Study to Investigate the Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine Formulations Compared With Licensed Meningococcal Vaccines When Administered Alone in Healthy Children (2 to 9 Years of Age) or Concomitantly With Routine Pediatric Vaccines in Toddlers (12 to 15 Months of Age) and Infants (2 Months of Age).",
"has_exemption": false,
"start_date": "2024-11-05",
"completion_date": "2027-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769698",
"publication_url": "https://clinicaltrials.gov/study/NCT06769698",
"title": "Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2027-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06713668",
"publication_url": "https://clinicaltrials.gov/study/NCT06713668",
"title": "Augmented Pacing for Shock in the Cardiac Intensive Care Unit - A Pilot Patient-level Crossover Trial",
"has_exemption": false,
"start_date": "2025-04-22",
"completion_date": "2027-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05639114",
"publication_url": "https://clinicaltrials.gov/study/NCT05639114",
"title": "A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)",
"has_exemption": false,
"start_date": "2023-03-02",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624749",
"publication_url": "https://clinicaltrials.gov/study/NCT05624749",
"title": "A Randomized, Double-blind, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)",
"has_exemption": false,
"start_date": "2023-04-21",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06163326",
"publication_url": "https://clinicaltrials.gov/study/NCT06163326",
"title": "A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTICENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305767",
"publication_url": "https://clinicaltrials.gov/study/NCT06305767",
"title": "A Phase 1/2 Study of V940 Plus Pembrolizumab With or Without Enfortumab Vedotin in Muscle-Invasive Urothelial Carcinoma (MIUC) (INTerpath-005)",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2027-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06242834",
"publication_url": "https://clinicaltrials.gov/study/NCT06242834",
"title": "Phase II, Single Arm, Open Label, Study of the Combination of Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-Cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2027-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04929392",
"publication_url": "https://clinicaltrials.gov/study/NCT04929392",
"title": "A Phase 2 Trial of Neoadjuvant Chemoradiation With Pembrolizumab Followed by Pembrolizumab With Lenvatinib in Esophageal/Gastroesophageal Junction Squamous Cell and Adenocarcinomas",
"has_exemption": false,
"start_date": "2022-01-25",
"completion_date": "2027-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731075",
"publication_url": "https://clinicaltrials.gov/study/NCT06731075",
"title": "A Double-Blinded, Placebo-controlled, Double Dummy, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on One to Three Glucose-lowering Agents",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2027-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Oramed, Ltd.",
"sponsor_slug": "oramed-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785624",
"publication_url": "https://clinicaltrials.gov/study/NCT05785624",
"title": "A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Idiopathic Pulmonary Fibrosis and in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease",
"has_exemption": false,
"start_date": "2023-05-26",
"completion_date": "2027-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06452277",
"publication_url": "https://clinicaltrials.gov/study/NCT06452277",
"title": "A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2027-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04959175",
"publication_url": "https://clinicaltrials.gov/study/NCT04959175",
"title": "Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies",
"has_exemption": false,
"start_date": "2021-09-23",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05379595",
"publication_url": "https://clinicaltrials.gov/study/NCT05379595",
"title": "A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2022-07-29",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06364917",
"publication_url": "https://clinicaltrials.gov/study/NCT06364917",
"title": "DISCERN: Dual Immune Strategy Versus Single Checkpoint Inhibition Efficacy Response in PDL-1 Negative Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023627",
"publication_url": "https://clinicaltrials.gov/study/NCT07023627",
"title": "A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression (MAESTRA 1)",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2027-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03173937",
"publication_url": "https://clinicaltrials.gov/study/NCT03173937",
"title": "Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, to Expedite Engraftment and Improve Transplant Outcome",
"has_exemption": false,
"start_date": "2017-06-13",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05529069",
"publication_url": "https://clinicaltrials.gov/study/NCT05529069",
"title": "Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06238622",
"publication_url": "https://clinicaltrials.gov/study/NCT06238622",
"title": "An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON)",
"has_exemption": false,
"start_date": "2024-05-06",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952556",
"publication_url": "https://clinicaltrials.gov/study/NCT06952556",
"title": "A Randomized, Single-blind, Single-center Study Measuring the Effects of Adductor Canal Block Combined With IPACK Infiltration Compared to Adductor Canal Block Alone on Post-operative Pain and Opioid Consumption in Patients Undergoing HTO/DFO/TTO",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07036523",
"publication_url": "https://clinicaltrials.gov/study/NCT07036523",
"title": "A Double-blind, Randomised, Placebo-controlled, Parallel Group, Phase IIa Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 765423 Administered Intravenously With or Without Standard of Care in Patients With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2027-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918132",
"publication_url": "https://clinicaltrials.gov/study/NCT06918132",
"title": "Phase II Single Arm Study of Neoadjuvant Dual Checkpoint Blockade With Programmed Death-ligand 1 (PD1) and Lymphocyte Activation Gene 3 (LAG-3) Inhibition in Resectable Non-Small Cell Lung Cancer (N-PLANC)",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2027-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01512589",
"publication_url": "https://clinicaltrials.gov/study/NCT01512589",
"title": "Phase IIB Randomized Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer",
"has_exemption": false,
"start_date": "2012-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01787487",
"publication_url": "https://clinicaltrials.gov/study/NCT01787487",
"title": "Evaluation of Ruxolitinib and Azacytidine Combination as a Therapy for Patients With Myelofibrosis and Myelodysplastic Syndrome/ Myeloproliferative Neoplasm",
"has_exemption": false,
"start_date": "2013-03-13",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02227251",
"publication_url": "https://clinicaltrials.gov/study/NCT02227251",
"title": "A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)",
"has_exemption": false,
"start_date": "2014-11-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Karyopharm Therapeutics Inc",
"sponsor_slug": "karyopharm-therapeutics-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02181257",
"publication_url": "https://clinicaltrials.gov/study/NCT02181257",
"title": "Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts",
"has_exemption": false,
"start_date": "2015-01-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02420860",
"publication_url": "https://clinicaltrials.gov/study/NCT02420860",
"title": "Phase II Study of the Combination of Elotuzumab With Lenalidomide as Maintenance Therapy Post Autologous Stem Cell Transplant in Patients With Multiple Myeloma",
"has_exemption": false,
"start_date": "2015-04-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02343042",
"publication_url": "https://clinicaltrials.gov/study/NCT02343042",
"title": "A Phase 1b/2 Study of Selinexor (KPT-330) in Combination With Backbone Treatments for Relapsed/Refractory Multiple Myeloma and Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2015-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Karyopharm Therapeutics Inc",
"sponsor_slug": "karyopharm-therapeutics-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02960555",
"publication_url": "https://clinicaltrials.gov/study/NCT02960555",
"title": "Phase II Trial of Isatuximab (SAR650984) With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)",
"has_exemption": false,
"start_date": "2017-02-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03090633",
"publication_url": "https://clinicaltrials.gov/study/NCT03090633",
"title": "Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida",
"has_exemption": false,
"start_date": "2017-05-11",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03360721",
"publication_url": "https://clinicaltrials.gov/study/NCT03360721",
"title": "A Phase 2, Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Metastatic Prostate Cancer Patients Evaluating a Predetermined Biomarker Signature",
"has_exemption": false,
"start_date": "2018-03-06",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03449108",
"publication_url": "https://clinicaltrials.gov/study/NCT03449108",
"title": "Clinical Study to Assess Efficacy and Safety of LN-145/LN-145-S1 (Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes) Across Multiple Tumor Types",
"has_exemption": false,
"start_date": "2018-04-27",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03463460",
"publication_url": "https://clinicaltrials.gov/study/NCT03463460",
"title": "A Multicenter, Phase II Trial of Pembrolizumab and Sunitinib in Refractory Advanced Thymic Carcinoma",
"has_exemption": false,
"start_date": "2018-06-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dwight Owen",
"sponsor_slug": "dwight-owen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03298334",
"publication_url": "https://clinicaltrials.gov/study/NCT03298334",
"title": "Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates: a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2018-07-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03540758",
"publication_url": "https://clinicaltrials.gov/study/NCT03540758",
"title": "Regulation of Endogenous Glucose Production by Central KATP Channels",
"has_exemption": false,
"start_date": "2018-08-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Meredith Hawkins",
"sponsor_slug": "meredith-hawkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03586609",
"publication_url": "https://clinicaltrials.gov/study/NCT03586609",
"title": "Phase II Study of Venetoclax Added to Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed by Consolidation With Cladribine Plus LDAC Alternating With 5-Azacitidine With Venetoclax in Patients With Untreated AML",
"has_exemption": false,
"start_date": "2018-10-25",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04145622",
"publication_url": "https://clinicaltrials.gov/study/NCT04145622",
"title": "Phase I/II, Two-Part, Multicenter First-in-Human Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Subjects With Advanced Solid Malignant Tumors (IDeate-PanTumor01)",
"has_exemption": false,
"start_date": "2019-11-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04176198",
"publication_url": "https://clinicaltrials.gov/study/NCT04176198",
"title": "A Phase 1/2, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral Nuvisertib (TP-3654) in Patients With Intermediate or High-Risk Primary or Secondary Myelofibrosis",
"has_exemption": false,
"start_date": "2019-12-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03907046",
"publication_url": "https://clinicaltrials.gov/study/NCT03907046",
"title": "Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery",
"has_exemption": false,
"start_date": "2020-01-28",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05986292",
"publication_url": "https://clinicaltrials.gov/study/NCT05986292",
"title": "A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain",
"has_exemption": false,
"start_date": "2020-01-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04280718",
"publication_url": "https://clinicaltrials.gov/study/NCT04280718",
"title": "Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2020-09-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04583644",
"publication_url": "https://clinicaltrials.gov/study/NCT04583644",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2020-10-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hanmin Lee",
"sponsor_slug": "hanmin-lee",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04402788",
"publication_url": "https://clinicaltrials.gov/study/NCT04402788",
"title": "RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial",
"has_exemption": false,
"start_date": "2021-01-07",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03608631",
"publication_url": "https://clinicaltrials.gov/study/NCT03608631",
"title": "Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation",
"has_exemption": false,
"start_date": "2021-01-27",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04370301",
"publication_url": "https://clinicaltrials.gov/study/NCT04370301",
"title": "Pilot Study of JAK Inhibitor Therapy Followed by Reduced Intensity Haploidentical Transplantation for Patients With Myelofibrosis",
"has_exemption": true,
"start_date": "2021-02-09",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03892980",
"publication_url": "https://clinicaltrials.gov/study/NCT03892980",
"title": "A Prospective, Multicenter Investigation of the da Vinci® Surgical Systems in Nipple Sparing Mastectomy (NSM) Procedures",
"has_exemption": false,
"start_date": "2021-03-26",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intuitive Surgical",
"sponsor_slug": "intuitive-surgical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05056844",
"publication_url": "https://clinicaltrials.gov/study/NCT05056844",
"title": "Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study",
"has_exemption": false,
"start_date": "2021-04-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04956640",
"publication_url": "https://clinicaltrials.gov/study/NCT04956640",
"title": "A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2021-07-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05050136",
"publication_url": "https://clinicaltrials.gov/study/NCT05050136",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis",
"has_exemption": false,
"start_date": "2021-09-22",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirum Pharmaceuticals, Inc.",
"sponsor_slug": "mirum-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04908423",
"publication_url": "https://clinicaltrials.gov/study/NCT04908423",
"title": "Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke",
"has_exemption": false,
"start_date": "2021-10-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04905069",
"publication_url": "https://clinicaltrials.gov/study/NCT04905069",
"title": "Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04988555",
"publication_url": "https://clinicaltrials.gov/study/NCT04988555",
"title": "A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of DSP-5336 in Adult Patients With Acute Leukemia and Other Selected Hematologic Malignancies, With and Without Mixed Lineage Leukemia (MLL) Rearrangement or Nucleophosmin 1 (NPM1) Mutation",
"has_exemption": false,
"start_date": "2022-02-28",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05353569",
"publication_url": "https://clinicaltrials.gov/study/NCT05353569",
"title": "Otitis Media Diagnosis and Treatment: Coherent Optical Detection of Middle Ear Disease",
"has_exemption": false,
"start_date": "2022-05-24",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04902703",
"publication_url": "https://clinicaltrials.gov/study/NCT04902703",
"title": "Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease (SESAD)",
"has_exemption": false,
"start_date": "2022-06-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06850922",
"publication_url": "https://clinicaltrials.gov/study/NCT06850922",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Patients With Diabetic Macular Edema",
"has_exemption": false,
"start_date": "2022-06-22",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05410145",
"publication_url": "https://clinicaltrials.gov/study/NCT05410145",
"title": "A Phase 1/2, Open Label, Dose-escalation, and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation",
"has_exemption": false,
"start_date": "2022-08-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "D3 Bio (Wuxi) Co., Ltd",
"sponsor_slug": "d3-bio-wuxi-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05285527",
"publication_url": "https://clinicaltrials.gov/study/NCT05285527",
"title": "MiSight 1 Day Safety Post-Approval Study",
"has_exemption": false,
"start_date": "2022-08-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Coopervision, Inc.",
"sponsor_slug": "coopervision-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05596318",
"publication_url": "https://clinicaltrials.gov/study/NCT05596318",
"title": "Efficacy of Digital Cognitive Behavior Therapy for Insomnia for the Prevention of Perinatal Depression",
"has_exemption": false,
"start_date": "2022-11-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05279742",
"publication_url": "https://clinicaltrials.gov/study/NCT05279742",
"title": "Enhancing the Natriuretic Peptide System in HFpEF: A Randomized Double-Blind Placebo-Controlled Triple Crossover Study",
"has_exemption": false,
"start_date": "2022-11-04",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Horng Chen",
"sponsor_slug": "horng-chen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05185505",
"publication_url": "https://clinicaltrials.gov/study/NCT05185505",
"title": "Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study",
"has_exemption": false,
"start_date": "2023-01-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667142",
"publication_url": "https://clinicaltrials.gov/study/NCT05667142",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures",
"has_exemption": false,
"start_date": "2023-02-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xenon Pharmaceuticals Inc.",
"sponsor_slug": "xenon-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118268",
"publication_url": "https://clinicaltrials.gov/study/NCT06118268",
"title": "iTBS to Enhance Social Cognition in People With Psychosis",
"has_exemption": false,
"start_date": "2023-04-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613608",
"publication_url": "https://clinicaltrials.gov/study/NCT05613608",
"title": "Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies",
"has_exemption": false,
"start_date": "2023-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646485",
"publication_url": "https://clinicaltrials.gov/study/NCT05646485",
"title": "Optimal Screening Strategy for Bladder Cancer in at Risk Patients",
"has_exemption": false,
"start_date": "2023-05-05",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05683691",
"publication_url": "https://clinicaltrials.gov/study/NCT05683691",
"title": "Prospective, Multicenter, Single-Arm Study of VanquishTM Water Vapor Ablation for PrOstate CanceR",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Francis Medical Inc.",
"sponsor_slug": "francis-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05703256",
"publication_url": "https://clinicaltrials.gov/study/NCT05703256",
"title": "Confirmatory Efficacy Randomized Clinical Trial of Amygdala Neurofeedback for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2023-06-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kymberly Young",
"sponsor_slug": "kymberly-young",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05531656",
"publication_url": "https://clinicaltrials.gov/study/NCT05531656",
"title": "Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Over 18 Months.",
"has_exemption": false,
"start_date": "2023-06-28",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cognition Therapeutics",
"sponsor_slug": "cognition-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907954",
"publication_url": "https://clinicaltrials.gov/study/NCT05907954",
"title": "(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma",
"has_exemption": false,
"start_date": "2023-07-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "IDEAYA Biosciences",
"sponsor_slug": "ideaya-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933148",
"publication_url": "https://clinicaltrials.gov/study/NCT05933148",
"title": "Network-based Real-time Neurofeedback Using Ultra-high Field MRI to Reduce Rumination Levels in Depression",
"has_exemption": false,
"start_date": "2023-07-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04808505",
"publication_url": "https://clinicaltrials.gov/study/NCT04808505",
"title": "An Open-label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Cipaglucosidase Alfa/Miglustat in Both ERT-experienced and ERT-naïve Pediatric Subjects With Infantile-onset Pompe Disease Aged 0 to < 18 Years",
"has_exemption": false,
"start_date": "2023-07-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Amicus Therapeutics",
"sponsor_slug": "amicus-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05559879",
"publication_url": "https://clinicaltrials.gov/study/NCT05559879",
"title": "A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women With Recurrent Gynecologic Carcinosarcoma",
"has_exemption": false,
"start_date": "2023-08-20",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05696626",
"publication_url": "https://clinicaltrials.gov/study/NCT05696626",
"title": "An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sermonix Pharmaceuticals Inc.",
"sponsor_slug": "sermonix-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05291676",
"publication_url": "https://clinicaltrials.gov/study/NCT05291676",
"title": "Systems Investigation of Vaccine Responses in Aging and Frailty",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111586",
"publication_url": "https://clinicaltrials.gov/study/NCT06111586",
"title": "A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2b Study With a 52-week Blinded Extension and an Optional Open-label Extension - Assessing Safety and Efficacy of Frexalimab, a CD40L-antagonist Monoclonal Antibody, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Newly Diagnosed Type 1 Diabetes on Insulin Therapy",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494891",
"publication_url": "https://clinicaltrials.gov/study/NCT06494891",
"title": "Translational Underpinnings of Motivation for Alcohol in Humans",
"has_exemption": false,
"start_date": "2024-01-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06244082",
"publication_url": "https://clinicaltrials.gov/study/NCT06244082",
"title": "A Phase 2 Open-label Study to Evaluate the Pharmacodynamics and Long-Term Safety and Tolerability of AOC 1044 Administered Intravenously to DMD Participants With Mutations Amenable to Exon 44 Skipping",
"has_exemption": false,
"start_date": "2024-01-22",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06189638",
"publication_url": "https://clinicaltrials.gov/study/NCT06189638",
"title": "A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients With Mild Infections of Diabetic Foot Ulcers",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.",
"sponsor_slug": "jiangsu-protelight-pharmaceutical-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06095505",
"publication_url": "https://clinicaltrials.gov/study/NCT06095505",
"title": "A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Puma Biotechnology, Inc.",
"sponsor_slug": "puma-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06458062",
"publication_url": "https://clinicaltrials.gov/study/NCT06458062",
"title": "Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06280352",
"publication_url": "https://clinicaltrials.gov/study/NCT06280352",
"title": "Prospective Randomized Controlled Trial of Functionally Aligned Robotically Assisted Total Knee Arthroplasty vs Patient Specific Custom Made Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Austrian Workers Compensation Board Styria",
"sponsor_slug": "austrian-workers-compensation-board-styria",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05932615",
"publication_url": "https://clinicaltrials.gov/study/NCT05932615",
"title": "Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement",
"has_exemption": false,
"start_date": "2024-03-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06257056",
"publication_url": "https://clinicaltrials.gov/study/NCT06257056",
"title": "Closed Loop Neuromodulation for Treatment-refractory Schizophrenia: A Pilot Study",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bradley Lega",
"sponsor_slug": "bradley-lega",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06152653",
"publication_url": "https://clinicaltrials.gov/study/NCT06152653",
"title": "The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC",
"has_exemption": false,
"start_date": "2024-04-09",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05830942",
"publication_url": "https://clinicaltrials.gov/study/NCT05830942",
"title": "Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05219175",
"publication_url": "https://clinicaltrials.gov/study/NCT05219175",
"title": "MDMA-Assisted Therapy 6 to 12 Months After Childbirth for People With Co-occurring Opioid Use and Post Traumatic Stress Disorders",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of New Mexico",
"sponsor_slug": "university-of-new-mexico",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377566",
"publication_url": "https://clinicaltrials.gov/study/NCT06377566",
"title": "BV-AVD in Patients With Newly-Diagnosed, Early Stage, Bulky Hodgkin Lymphoma Using a PET-adapted and MTV-guided Approach",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05988918",
"publication_url": "https://clinicaltrials.gov/study/NCT05988918",
"title": "A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06394804",
"publication_url": "https://clinicaltrials.gov/study/NCT06394804",
"title": "Combination Targeted and Hormonal treAtMEnt of Low-gradE Serous Ovarian Cancer in the upfroNt Setting",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06048484",
"publication_url": "https://clinicaltrials.gov/study/NCT06048484",
"title": "A Phase 2, Open-Label, Multicenter, Randomized Study Evaluating Neoadjuvant Therapy Targeting the Adenosine Immunosuppressive Pathway in Combination With Immune Checkpoint Blockade and Radiation Therapy in Patients With Advanced PANCreatic Ductal Adenocarcinoma Who Are Candidates for Surgical Resection",
"has_exemption": false,
"start_date": "2024-05-10",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gulam Manji",
"sponsor_slug": "gulam-manji",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06372964",
"publication_url": "https://clinicaltrials.gov/study/NCT06372964",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lumateperone for the Treatment of Major Depressive Episodes (MDEs) Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) in Pediatric Patients Aged 10 to 17 Years",
"has_exemption": false,
"start_date": "2024-05-13",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05419492",
"publication_url": "https://clinicaltrials.gov/study/NCT05419492",
"title": "ENDEAVOR: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Infants and Children With SCN1A-Positive Dravet Syndrome",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Encoded Therapeutics",
"sponsor_slug": "encoded-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06321302",
"publication_url": "https://clinicaltrials.gov/study/NCT06321302",
"title": "CRIMSON: A Multicentre, Randomised, Sham-controlled (and Active Controlled in the USA), Double-masked, 72-week Trial to Study the Safety, Tolerability, Pharmacokinetics, and Efficacy of 3 Dosing Regimens of Intravitreal BI 764524 in Patients With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06203210",
"publication_url": "https://clinicaltrials.gov/study/NCT06203210",
"title": "A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06278779",
"publication_url": "https://clinicaltrials.gov/study/NCT06278779",
"title": "Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-Resistant Depression: a Randomised, Rater-blinded Trial",
"has_exemption": false,
"start_date": "2024-06-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The George Institute",
"sponsor_slug": "the-george-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384664",
"publication_url": "https://clinicaltrials.gov/study/NCT06384664",
"title": "Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy",
"has_exemption": false,
"start_date": "2024-06-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06557265",
"publication_url": "https://clinicaltrials.gov/study/NCT06557265",
"title": "A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Autoimmune Disease",
"has_exemption": false,
"start_date": "2024-06-13",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nkarta, Inc.",
"sponsor_slug": "nkarta-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399757",
"publication_url": "https://clinicaltrials.gov/study/NCT06399757",
"title": "A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apollo Therapeutics Ltd",
"sponsor_slug": "apollo-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06162572",
"publication_url": "https://clinicaltrials.gov/study/NCT06162572",
"title": "A Phase 1b/2, Multicenter, Open-label Platform Study of Select Immunotherapy Combinations in Adult Participants With Previously Untreated Advanced Non-small Cell Lung Cancer (NSCLC) With High PD-L1 Expression",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06409390",
"publication_url": "https://clinicaltrials.gov/study/NCT06409390",
"title": "A Pilot Study of Sequential (\"First Strike, Second Strike\") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for Hormone Positive Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06423430",
"publication_url": "https://clinicaltrials.gov/study/NCT06423430",
"title": "Treatment ResistAnt Depression Subcallosal CingulatE Network DBS",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384976",
"publication_url": "https://clinicaltrials.gov/study/NCT06384976",
"title": "KYSA-7: A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2024-09-20",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyverna Therapeutics",
"sponsor_slug": "kyverna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456567",
"publication_url": "https://clinicaltrials.gov/study/NCT06456567",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept Compared to Placebo in Patients With Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "RemeGen Co., Ltd.",
"sponsor_slug": "remegen-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06598462",
"publication_url": "https://clinicaltrials.gov/study/NCT06598462",
"title": "A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study With an Extension to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis (ALAMERE)",
"has_exemption": false,
"start_date": "2024-10-16",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Uniquity One (UNI)",
"sponsor_slug": "uniquity-one-uni",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06656364",
"publication_url": "https://clinicaltrials.gov/study/NCT06656364",
"title": "Esprit BTK Post-Approval Study (Esprit BTK PAS)",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384651",
"publication_url": "https://clinicaltrials.gov/study/NCT06384651",
"title": "Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494904",
"publication_url": "https://clinicaltrials.gov/study/NCT06494904",
"title": "ED-Initiated Standard Versus High Dose Buprenorphine Induction",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06489028",
"publication_url": "https://clinicaltrials.gov/study/NCT06489028",
"title": "A Pivotal, Randomized, Placebo-controlled, Double-blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "RHEACELL GmbH & Co. KG",
"sponsor_slug": "rheacell-gmbh-co-kg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06696313",
"publication_url": "https://clinicaltrials.gov/study/NCT06696313",
"title": "Radiographic Migration Analysis of the Insignia Hip Stem",
"has_exemption": false,
"start_date": "2024-12-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Radiostereometric Analysis Network",
"sponsor_slug": "canadian-radiostereometric-analysis-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06596291",
"publication_url": "https://clinicaltrials.gov/study/NCT06596291",
"title": "First-In-Human Phase 1b/2a Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adult Participants With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "EG 427",
"sponsor_slug": "eg-427",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032285",
"publication_url": "https://clinicaltrials.gov/study/NCT07032285",
"title": "Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas",
"sponsor_slug": "asociacion-europea-y-latinoamericana-selnet-para-la-investigacion-en-sarcomas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06558188",
"publication_url": "https://clinicaltrials.gov/study/NCT06558188",
"title": "Combined Anabolic Therapy Study",
"has_exemption": false,
"start_date": "2025-02-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06289491",
"publication_url": "https://clinicaltrials.gov/study/NCT06289491",
"title": "Randomized Trial of Hydrus Microstent Versus Goniotomy",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts Eye and Ear Infirmary",
"sponsor_slug": "massachusetts-eye-and-ear-infirmary",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980805",
"publication_url": "https://clinicaltrials.gov/study/NCT06980805",
"title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453785",
"publication_url": "https://clinicaltrials.gov/study/NCT06453785",
"title": "Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Imperial College London",
"sponsor_slug": "imperial-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06895473",
"publication_url": "https://clinicaltrials.gov/study/NCT06895473",
"title": "A Phase 2 Study of Prophylactic IT Chemotherapy to Prevent High-Grade Chimeric Antigen Receptor (CAR) T-Cell-Associated Neurotoxicity Syndrome",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925724",
"publication_url": "https://clinicaltrials.gov/study/NCT06925724",
"title": "A Phase 2 Study of Ivonescimab (Bispecific Antibody Against PD1 and VEGF) For the Treatment of Endometrial (EC) and Cervical (CC) Cancers",
"has_exemption": false,
"start_date": "2025-04-04",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957327",
"publication_url": "https://clinicaltrials.gov/study/NCT06957327",
"title": "A Phase 1b/2 Study of ERAS-601 SHP2 Inhibitor as a Monotherapy in Patients With Advanced and Progressing Chordoma",
"has_exemption": false,
"start_date": "2025-04-25",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470035",
"publication_url": "https://clinicaltrials.gov/study/NCT06470035",
"title": "A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Major Depressive Disorder (MDD) - Modius Mood Study",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurovalens Ltd.",
"sponsor_slug": "neurovalens-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915662",
"publication_url": "https://clinicaltrials.gov/study/NCT06915662",
"title": "Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap: A Prospective Trial for Safety and Efficacy",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06962280",
"publication_url": "https://clinicaltrials.gov/study/NCT06962280",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Tirzepatide Once Weekly Compared to Placebo in Adults With Type 1 Diabetes and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020026",
"publication_url": "https://clinicaltrials.gov/study/NCT07020026",
"title": "Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease Using [18F]PI-2620: A High-resolution PET Imaging Study Using NeuroEXPLORER (NX PI-2160 in PD)",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael J. Fox Foundation for Parkinson's Research",
"sponsor_slug": "michael-j-fox-foundation-for-parkinsons-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05536739",
"publication_url": "https://clinicaltrials.gov/study/NCT05536739",
"title": "Adaptive Hip Exoskeleton for Stroke Survivors With Gait Impairment",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Georgia Institute of Technology",
"sponsor_slug": "georgia-institute-of-technology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999278",
"publication_url": "https://clinicaltrials.gov/study/NCT06999278",
"title": "LIGHT - Levothyroxine for Isolated Gestational HypoThyroidism in Women With Recurrent Pregnancy Loss: a Multicenter Randomized, Double-blind, Placebo-controlled Trial - a Study Protocol",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Women's Hospital School Of Medicine Zhejiang University",
"sponsor_slug": "womens-hospital-school-of-medicine-zhejiang-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735534",
"publication_url": "https://clinicaltrials.gov/study/NCT06735534",
"title": "The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06968494",
"publication_url": "https://clinicaltrials.gov/study/NCT06968494",
"title": "Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Comphya Inc.",
"sponsor_slug": "comphya-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999304",
"publication_url": "https://clinicaltrials.gov/study/NCT06999304",
"title": "Personalized Accelerated Theta Burst Transcardial Magnetic Stimulation in Mild Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "HealthPartners Institute",
"sponsor_slug": "healthpartners-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740890",
"publication_url": "https://clinicaltrials.gov/study/NCT06740890",
"title": "A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06767956",
"publication_url": "https://clinicaltrials.gov/study/NCT06767956",
"title": "Phase I/II Study of Combination Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Natalie Galanina",
"sponsor_slug": "natalie-galanina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07033026",
"publication_url": "https://clinicaltrials.gov/study/NCT07033026",
"title": "A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NGM Biopharmaceuticals, Inc",
"sponsor_slug": "ngm-biopharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03301805",
"publication_url": "https://clinicaltrials.gov/study/NCT03301805",
"title": "A Phase II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Gemcitabine Monotherapy in Patients With Advanced Inoperable or Metastatic Pancreatic Cancer",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rgene Corporation",
"sponsor_slug": "rgene-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07025720",
"publication_url": "https://clinicaltrials.gov/study/NCT07025720",
"title": "Personalized Accelerated Intermittent Theta Burst Stimulation for Post-Acute Suicidal Ideation",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095660",
"publication_url": "https://clinicaltrials.gov/study/NCT07095660",
"title": "RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intervene, Inc.",
"sponsor_slug": "intervene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217392",
"publication_url": "https://clinicaltrials.gov/study/NCT07217392",
"title": "Left Bundle Branch Area Pacing (LBBAP) PMCF Study",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079761",
"publication_url": "https://clinicaltrials.gov/study/NCT07079761",
"title": "Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06864403",
"publication_url": "https://clinicaltrials.gov/study/NCT06864403",
"title": "Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch",
"has_exemption": false,
"start_date": "2025-08-12",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07105111",
"publication_url": "https://clinicaltrials.gov/study/NCT07105111",
"title": "A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor",
"has_exemption": false,
"start_date": "2025-08-29",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999603",
"publication_url": "https://clinicaltrials.gov/study/NCT06999603",
"title": "A Phase 2, Two-part Study to Assess the Safety, Antiviral Biomarker Responses, and Efficacy of Inhaled SNG001 for the Treatment of Patients With a Confirmed Respiratory Virus Infection Undergoing Invasive Mechanical Ventilation",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Synairgen Research Ltd.",
"sponsor_slug": "synairgen-research-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07146230",
"publication_url": "https://clinicaltrials.gov/study/NCT07146230",
"title": "The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial 2 (SPRINT 2)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220460",
"publication_url": "https://clinicaltrials.gov/study/NCT07220460",
"title": "Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07051031",
"publication_url": "https://clinicaltrials.gov/study/NCT07051031",
"title": "Reactogenicity, Patient Reported Outcomes and Vaccine Preference in Adults Immunized With Recombinant Protein or mRNA COVID-19 Vaccines",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Marcel Curlin",
"sponsor_slug": "marcel-curlin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219771",
"publication_url": "https://clinicaltrials.gov/study/NCT07219771",
"title": "A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2025-10-14",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Doron Therapeutics Inc.",
"sponsor_slug": "doron-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222969",
"publication_url": "https://clinicaltrials.gov/study/NCT07222969",
"title": "An Open-label, Dose-escalation and Dose-expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Efficacy of VIB305 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vibrant Sciences Limited",
"sponsor_slug": "vibrant-sciences-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06968143",
"publication_url": "https://clinicaltrials.gov/study/NCT06968143",
"title": "Evaluating the Impact of Remote Therapeutic Monitoring on Knee Arthroplasty Recovery",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07141342",
"publication_url": "https://clinicaltrials.gov/study/NCT07141342",
"title": "The Fast In-Bed Tracking (FIT) System Lifestyle Intervention",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathan Pearlman",
"sponsor_slug": "jonathan-pearlman",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07175441",
"publication_url": "https://clinicaltrials.gov/study/NCT07175441",
"title": "A Phase 2a, Multicenter, Randomized, Open-Label Study to Assess the Efficacy, Safety, and Tolerability of RBS2418 in Combination With Tremelimumab Plus Durvalumab for Participants With Advanced Unresectable Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Riboscience, LLC.",
"sponsor_slug": "riboscience-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220811",
"publication_url": "https://clinicaltrials.gov/study/NCT07220811",
"title": "Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "RAPT Therapeutics, Inc.",
"sponsor_slug": "rapt-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221734",
"publication_url": "https://clinicaltrials.gov/study/NCT07221734",
"title": "Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "mAbxience Research S.L.",
"sponsor_slug": "mabxience-research-sl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804811",
"publication_url": "https://clinicaltrials.gov/study/NCT06804811",
"title": "A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06748144",
"publication_url": "https://clinicaltrials.gov/study/NCT06748144",
"title": "Intraosseous vs. Intravenous Vancomycin Administration in Spine Surgery",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224958",
"publication_url": "https://clinicaltrials.gov/study/NCT07224958",
"title": "ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875206",
"publication_url": "https://clinicaltrials.gov/study/NCT06875206",
"title": "Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07078604",
"publication_url": "https://clinicaltrials.gov/study/NCT07078604",
"title": "A Phase II Trial of the Immunogenicity of a DNA Plasmid-Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes From Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Patients With Metastatic Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224672",
"publication_url": "https://clinicaltrials.gov/study/NCT07224672",
"title": "A Phase 2, Open-label, Single-arm, Proof-of-concept Study Evaluating the Efficacy and Safety of Belantamab Mafodotin Administered in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain Amyloidosis (ALANIS)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05974202",
"publication_url": "https://clinicaltrials.gov/study/NCT05974202",
"title": "Augmenting Cognitive-behavioral Therapy With rTMS of the Medial Prefrontal and Anterior Cingulate Cortices for the Treatment of Cocaine Use Disorder",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06658899",
"publication_url": "https://clinicaltrials.gov/study/NCT06658899",
"title": "A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cardurion Pharmaceuticals, Inc.",
"sponsor_slug": "cardurion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06840899",
"publication_url": "https://clinicaltrials.gov/study/NCT06840899",
"title": "Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07090135",
"publication_url": "https://clinicaltrials.gov/study/NCT07090135",
"title": "Enhance the Restorative Power of Sleep Through TES-TI Power Naps",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07111013",
"publication_url": "https://clinicaltrials.gov/study/NCT07111013",
"title": "A 12-Month, Multicenter, Open-Label Extension (OLE) Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch & Lomb Incorporated",
"sponsor_slug": "bausch-lomb-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02802423",
"publication_url": "https://clinicaltrials.gov/study/NCT02802423",
"title": "A Multi-Center, Randomized, Double Blind, Placebo-Controlled, Phase IIA Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid With Adjuvant Chemotherapy in Patients With Triple Negative Breast Cancer (TNBC) After Surgery",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioLite, Inc.",
"sponsor_slug": "biolite-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070089",
"publication_url": "https://clinicaltrials.gov/study/NCT07070089",
"title": "BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sonorous NV, Inc",
"sponsor_slug": "sonorous-nv-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06623305",
"publication_url": "https://clinicaltrials.gov/study/NCT06623305",
"title": "Photobiomodulation Therapy for the Prevention and Treatment of Mucositis in Pediatric Oncology Patients",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045298",
"publication_url": "https://clinicaltrials.gov/study/NCT07045298",
"title": "Real-Time Continuous Glucose Monitoring for the Management of Patients With Type 2 Diabetes and Acutely Decompensated Heart Failure",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2027-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02438904",
"publication_url": "https://clinicaltrials.gov/study/NCT02438904",
"title": "Compassionate Access of the Miltenyi Device for CD34+ Cell Selection",
"has_exemption": false,
"start_date": "2015-05-06",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03793478",
"publication_url": "https://clinicaltrials.gov/study/NCT03793478",
"title": "A Phase 1/2, Multicenter, Dose-Escalating Study To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy Of Quizartinib Administered in Combination With Re-Induction Chemotherapy, and as a Single-Agent Continuation Therapy, in Pediatric Relapsed/Refractory AML Subjects Aged 1 Month to <18 Years (and Young Adults Aged up to 21 Years) With FLT3-ITD Mutations",
"has_exemption": false,
"start_date": "2018-08-15",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04256317",
"publication_url": "https://clinicaltrials.gov/study/NCT04256317",
"title": "A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects With Myeloid Neoplasm or in Combination With Venetoclax in Subjects With AML (AZTOUND Study)",
"has_exemption": false,
"start_date": "2020-05-21",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Oncology, Inc.",
"sponsor_slug": "taiho-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05333458",
"publication_url": "https://clinicaltrials.gov/study/NCT05333458",
"title": "A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)",
"has_exemption": false,
"start_date": "2022-08-29",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05313165",
"publication_url": "https://clinicaltrials.gov/study/NCT05313165",
"title": "Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial",
"has_exemption": false,
"start_date": "2022-12-22",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "LimFlow, Inc.",
"sponsor_slug": "limflow-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023329",
"publication_url": "https://clinicaltrials.gov/study/NCT06023329",
"title": "Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery",
"has_exemption": false,
"start_date": "2023-01-03",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05524064",
"publication_url": "https://clinicaltrials.gov/study/NCT05524064",
"title": "FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05331170",
"publication_url": "https://clinicaltrials.gov/study/NCT05331170",
"title": "Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma VIRAL MUCOSAL REPROGRAMMING",
"has_exemption": false,
"start_date": "2023-04-27",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669027",
"publication_url": "https://clinicaltrials.gov/study/NCT05669027",
"title": "Effective Self-Management of Chronic Pain With mHealth Neurofeedback",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04808427",
"publication_url": "https://clinicaltrials.gov/study/NCT04808427",
"title": "Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation",
"has_exemption": false,
"start_date": "2023-11-20",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05938036",
"publication_url": "https://clinicaltrials.gov/study/NCT05938036",
"title": "PUERTA: A P2A Multi-center, Randomized, Double-blind, Placebo-controlled Study Assessing Safety and Efficacy of the eNAMPT Targeting mAb ALT-100 in Moderate/Severe ARDS/VILI Patients",
"has_exemption": false,
"start_date": "2023-12-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Aqualung Therapeutics Corp.",
"sponsor_slug": "aqualung-therapeutics-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05593497",
"publication_url": "https://clinicaltrials.gov/study/NCT05593497",
"title": "Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss",
"has_exemption": false,
"start_date": "2024-05-31",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377696",
"publication_url": "https://clinicaltrials.gov/study/NCT06377696",
"title": "Neuro-Oncology Anywhere: Deploying Mayo Clinic's Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin on Cognition and Quality of Life in Patients With History of Cranial Radiation",
"has_exemption": false,
"start_date": "2024-05-31",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06524414",
"publication_url": "https://clinicaltrials.gov/study/NCT06524414",
"title": "A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Infants",
"has_exemption": false,
"start_date": "2024-07-25",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06308588",
"publication_url": "https://clinicaltrials.gov/study/NCT06308588",
"title": "Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06548412",
"publication_url": "https://clinicaltrials.gov/study/NCT06548412",
"title": "CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2025-01-22",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06915727",
"publication_url": "https://clinicaltrials.gov/study/NCT06915727",
"title": "Pafolacianine for Localization of Pediatric Extracranial Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424067",
"publication_url": "https://clinicaltrials.gov/study/NCT06424067",
"title": "A Phase II Study of Fingolimod in Patients With Non-Small Cell and Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627751",
"publication_url": "https://clinicaltrials.gov/study/NCT06627751",
"title": "Phase II Clinical Trial of Mezigdomide/Carfilzomib/Dexamethasone (MeziKD) in Patients With Relapsed or Refractory Multiple Myeloma (MM) With Extramedullary Disease (EMD)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06928766",
"publication_url": "https://clinicaltrials.gov/study/NCT06928766",
"title": "Effects of Eszopiclone and Lemborexant in People With Obstructive Sleep Apnoea (OSA) With a Low Arousal Threshold Who Have Difficulty Maintaining or Falling Asleep (ELOSA): A Double-blind, Placebo-controlled, Randomised, Trial.",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Flinders University",
"sponsor_slug": "flinders-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06600698",
"publication_url": "https://clinicaltrials.gov/study/NCT06600698",
"title": "Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial)",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06834607",
"publication_url": "https://clinicaltrials.gov/study/NCT06834607",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Akhilesh Jain",
"sponsor_slug": "akhilesh-jain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943534",
"publication_url": "https://clinicaltrials.gov/study/NCT06943534",
"title": "Omalizumab Weight-Based Dosing Efficacy Trial",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943664",
"publication_url": "https://clinicaltrials.gov/study/NCT06943664",
"title": "Phase II Trial: Photoimmunotherapy and Anti-PD1 in Patients With Refractory Inoperable and Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217405",
"publication_url": "https://clinicaltrials.gov/study/NCT07217405",
"title": "Low-Dose Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224971",
"publication_url": "https://clinicaltrials.gov/study/NCT07224971",
"title": "Assessing the Impact of Circadian Rhythm on Anti-PD-1/PD-L1 Immunotherapy",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Liza Villaruz, MD",
"sponsor_slug": "liza-villaruz-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06751992",
"publication_url": "https://clinicaltrials.gov/study/NCT06751992",
"title": "Neurocognitive Function Changes With Once-Daily Extended-Release Tacrolimus (Envarsus XR) Conversion Compared to Twice-Daily Immediate Release Tacrolimus Maintenance Among Older Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071961",
"publication_url": "https://clinicaltrials.gov/study/NCT07071961",
"title": "Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05060549",
"publication_url": "https://clinicaltrials.gov/study/NCT05060549",
"title": "Dopamine D3 Receptor Occupancy in Bipolar Depression by Cariprazine (Vraylar): Evaluating Its Antidepressant Benefit",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04381897",
"publication_url": "https://clinicaltrials.gov/study/NCT04381897",
"title": "Use of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot Study",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2027-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807268",
"publication_url": "https://clinicaltrials.gov/study/NCT06807268",
"title": "A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2027-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03591510",
"publication_url": "https://clinicaltrials.gov/study/NCT03591510",
"title": "A Phase II, Open-label, Single Arm Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Twice Daily Midostaurin (PKC412) Combined With Standard Chemotherapy and as a Single Agent Post-consolidation Therapy in Children With Untreated FLT3-mutated AML",
"has_exemption": false,
"start_date": "2019-03-13",
"completion_date": "2027-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02628067",
"publication_url": "https://clinicaltrials.gov/study/NCT02628067",
"title": "A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)",
"has_exemption": false,
"start_date": "2015-12-18",
"completion_date": "2027-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07037004",
"publication_url": "https://clinicaltrials.gov/study/NCT07037004",
"title": "Impact of Microbiome Modulation With CBM588 in Combination With Pembrolizumab for Adjuvant Therapy of High-Risk, Resected Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2027-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428396",
"publication_url": "https://clinicaltrials.gov/study/NCT06428396",
"title": "A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive, HER2 Negative Unresectable Locally Advanced or Metastic Breast Cancer After Progression on Previous Endocrine Therapy (LITESPARK-029)",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2027-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05063162",
"publication_url": "https://clinicaltrials.gov/study/NCT05063162",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)",
"has_exemption": false,
"start_date": "2022-02-02",
"completion_date": "2027-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06141473",
"publication_url": "https://clinicaltrials.gov/study/NCT06141473",
"title": "Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2027-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06138639",
"publication_url": "https://clinicaltrials.gov/study/NCT06138639",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)",
"has_exemption": false,
"start_date": "2024-05-06",
"completion_date": "2027-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Solid Biosciences Inc.",
"sponsor_slug": "solid-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03229200",
"publication_url": "https://clinicaltrials.gov/study/NCT03229200",
"title": "Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials.",
"has_exemption": false,
"start_date": "2017-05-22",
"completion_date": "2027-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmacyclics Switzerland GmbH",
"sponsor_slug": "pharmacyclics-switzerland-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06074588",
"publication_url": "https://clinicaltrials.gov/study/NCT06074588",
"title": "A Randomized, Open-label, Phase 3 Study of MK-2870 vs Chemotherapy (Docetaxel or Pemetrexed) in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations",
"has_exemption": false,
"start_date": "2023-11-12",
"completion_date": "2027-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06094010",
"publication_url": "https://clinicaltrials.gov/study/NCT06094010",
"title": "A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Patients With Influenza and Transmission of Influenza to Household Contacts",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2027-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05726383",
"publication_url": "https://clinicaltrials.gov/study/NCT05726383",
"title": "MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Osteosarcoma After Resection Of Pulmonary Metastases",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2027-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868212",
"publication_url": "https://clinicaltrials.gov/study/NCT06868212",
"title": "A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihistamines",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2027-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07139951",
"publication_url": "https://clinicaltrials.gov/study/NCT07139951",
"title": "Prophylactic Hyperthermic Intraperitoneal Chemotherapy (p-HIPEC) for Gastric Cancer at High Risk of Peritoneal Recurrence",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2027-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824194",
"publication_url": "https://clinicaltrials.gov/study/NCT06824194",
"title": "A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2 Arm Study to Investigate the Safety of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers",
"has_exemption": false,
"start_date": "2025-02-18",
"completion_date": "2027-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05327114",
"publication_url": "https://clinicaltrials.gov/study/NCT05327114",
"title": "Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2022-09-23",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06230224",
"publication_url": "https://clinicaltrials.gov/study/NCT06230224",
"title": "A Phase 3, Randomized, Open Label Study Evaluating the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, Versus Standard of Care Therapy in Participants With Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06455449",
"publication_url": "https://clinicaltrials.gov/study/NCT06455449",
"title": "A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)",
"has_exemption": false,
"start_date": "2024-06-20",
"completion_date": "2027-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05343013",
"publication_url": "https://clinicaltrials.gov/study/NCT05343013",
"title": "TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy",
"has_exemption": false,
"start_date": "2022-06-06",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05267821",
"publication_url": "https://clinicaltrials.gov/study/NCT05267821",
"title": "Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS)",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05465941",
"publication_url": "https://clinicaltrials.gov/study/NCT05465941",
"title": "Phase II Clinical Trial of PLX038 in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05662319",
"publication_url": "https://clinicaltrials.gov/study/NCT05662319",
"title": "A Phase 3, Single-arm, Multicenter, Multinational, Open-label, One-way Crossover Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged ≥ 12 Years With Severe Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IX",
"has_exemption": false,
"start_date": "2023-02-01",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445062",
"publication_url": "https://clinicaltrials.gov/study/NCT06445062",
"title": "A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06448026",
"publication_url": "https://clinicaltrials.gov/study/NCT06448026",
"title": "Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2027-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06912646",
"publication_url": "https://clinicaltrials.gov/study/NCT06912646",
"title": "An Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2027-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Erchonia Corporation",
"sponsor_slug": "erchonia-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979362",
"publication_url": "https://clinicaltrials.gov/study/NCT06979362",
"title": "Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2027-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979375",
"publication_url": "https://clinicaltrials.gov/study/NCT06979375",
"title": "Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04322370",
"publication_url": "https://clinicaltrials.gov/study/NCT04322370",
"title": "Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries",
"has_exemption": false,
"start_date": "2020-08-21",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05878717",
"publication_url": "https://clinicaltrials.gov/study/NCT05878717",
"title": "A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)",
"has_exemption": false,
"start_date": "2023-09-13",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06290128",
"publication_url": "https://clinicaltrials.gov/study/NCT06290128",
"title": "A Phase 3, Double-blind, Placebo-controlled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy",
"has_exemption": false,
"start_date": "2024-07-12",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736041",
"publication_url": "https://clinicaltrials.gov/study/NCT06736041",
"title": "A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2027-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660667",
"publication_url": "https://clinicaltrials.gov/study/NCT06660667",
"title": "A Phase 1/2 Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR402663 in Participants With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2027-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06671483",
"publication_url": "https://clinicaltrials.gov/study/NCT06671483",
"title": "A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2027-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06671496",
"publication_url": "https://clinicaltrials.gov/study/NCT06671496",
"title": "A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2027-05-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04607954",
"publication_url": "https://clinicaltrials.gov/study/NCT04607954",
"title": "MC1923 Phase II Clinical Trial of Durvalumab (MEDI4736) and Lurbinectedin in Patients With Relapsed Extensive Stage Small Cell Lung Cancer Previously Treated With Chemotherapy and Immunotherapy",
"has_exemption": false,
"start_date": "2020-12-04",
"completion_date": "2027-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624554",
"publication_url": "https://clinicaltrials.gov/study/NCT05624554",
"title": "A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Without TP53 Aberrations",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2027-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01473628",
"publication_url": "https://clinicaltrials.gov/study/NCT01473628",
"title": "Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II",
"has_exemption": false,
"start_date": "2013-05-20",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03958877",
"publication_url": "https://clinicaltrials.gov/study/NCT03958877",
"title": "An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension",
"has_exemption": false,
"start_date": "2019-10-18",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568237",
"publication_url": "https://clinicaltrials.gov/study/NCT06568237",
"title": "A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Teva Branded Pharmaceutical Products, R&D Inc.",
"sponsor_slug": "teva-branded-pharmaceutical-products-rd-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06465329",
"publication_url": "https://clinicaltrials.gov/study/NCT06465329",
"title": "A Randomized Phase 2 Platform Study to Evaluate Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for the Perioperative Treatment of Patients With Resectable Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311227",
"publication_url": "https://clinicaltrials.gov/study/NCT06311227",
"title": "A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2027-05-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05132504",
"publication_url": "https://clinicaltrials.gov/study/NCT05132504",
"title": "Phase II Study of Neoadjuvant Folfirinox Chemotherapy Followed by Pembrolizumab Followed by Surgery for Patients With Localized, Resectable Adenocarcinoma of the Pancreas",
"has_exemption": false,
"start_date": "2022-08-31",
"completion_date": "2027-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227831",
"publication_url": "https://clinicaltrials.gov/study/NCT07227831",
"title": "A Phase 2 Study of TheraBionic P1 Device for Patients With Metastatic Hormone Positive Breast Cancer Post Endocrine Therapy",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2027-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Barbara Ann Karmanos Cancer Institute",
"sponsor_slug": "barbara-ann-karmanos-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05886634",
"publication_url": "https://clinicaltrials.gov/study/NCT05886634",
"title": "A Phase II Study of Adenosine Receptor (A2A and A2B) Inhibition (AB928) in Combination With Anti-PD-1 Therapy (AB122) in Patients With Advanced Dedifferentiated Liposarcoma",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2027-05-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049159",
"publication_url": "https://clinicaltrials.gov/study/NCT07049159",
"title": "A Two-stage, Phase 2b, Randomized, Double-blind, Placebo-controlled Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-05-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Eveliqure Biotechnologies GmbH",
"sponsor_slug": "eveliqure-biotechnologies-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157567",
"publication_url": "https://clinicaltrials.gov/study/NCT06157567",
"title": "Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System",
"has_exemption": false,
"start_date": "2022-05-24",
"completion_date": "2027-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05865028",
"publication_url": "https://clinicaltrials.gov/study/NCT05865028",
"title": "Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia",
"has_exemption": false,
"start_date": "2023-05-24",
"completion_date": "2027-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Elizabeth J Franzmann",
"sponsor_slug": "elizabeth-j-franzmann",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220577",
"publication_url": "https://clinicaltrials.gov/study/NCT07220577",
"title": "A Multicenter, Randomized, Participant- and Investigator -Blinded, Placebo-controlled, Phase 2a Study to Assess the Efficacy, Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2027-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222917",
"publication_url": "https://clinicaltrials.gov/study/NCT07222917",
"title": "A Phase IIb, Randomised, Multicentre, Double-Blind Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2027-05-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05067140",
"publication_url": "https://clinicaltrials.gov/study/NCT05067140",
"title": "A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination With Abiraterone in Patients With Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05519878",
"publication_url": "https://clinicaltrials.gov/study/NCT05519878",
"title": "Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers",
"has_exemption": false,
"start_date": "2022-11-29",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06327113",
"publication_url": "https://clinicaltrials.gov/study/NCT06327113",
"title": "A Phase 2 Randomized Study Comparing Subcutaneous Tumescent Antibiotic Administration With Standard of Care for the Treatment of Chronic Wounds",
"has_exemption": false,
"start_date": "2024-05-17",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06865079",
"publication_url": "https://clinicaltrials.gov/study/NCT06865079",
"title": "A Randomized, Double-blind, Placebo-controlled, 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Severe Tibio- Femoral Osteoarthritis of the Knee",
"has_exemption": false,
"start_date": "2025-05-09",
"completion_date": "2027-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "OrthoTrophix, Inc",
"sponsor_slug": "orthotrophix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06453213",
"publication_url": "https://clinicaltrials.gov/study/NCT06453213",
"title": "Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2027-05-26",
"has_results": false,
"results_due": false,
"sponsor_name": "SK Life Science, Inc.",
"sponsor_slug": "sk-life-science-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220642",
"publication_url": "https://clinicaltrials.gov/study/NCT07220642",
"title": "Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2027-05-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04785287",
"publication_url": "https://clinicaltrials.gov/study/NCT04785287",
"title": "Phase I/II Trial of Anti-CTLA4-NF mAb (BMS-986218) in Combination With Nivolumab and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2027-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05173987",
"publication_url": "https://clinicaltrials.gov/study/NCT05173987",
"title": "A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting (KEYNOTE-C93/GOG-3064/ENGOT-en15)",
"has_exemption": false,
"start_date": "2022-02-03",
"completion_date": "2027-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06531941",
"publication_url": "https://clinicaltrials.gov/study/NCT06531941",
"title": "An Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism Who Completed the 12-Week Treatment Period in the Phase 2 Study, MBX-2H1002 Study (Avail-Ext)",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2027-05-27",
"has_results": false,
"results_due": false,
"sponsor_name": "MBX Biosciences",
"sponsor_slug": "mbx-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04879862",
"publication_url": "https://clinicaltrials.gov/study/NCT04879862",
"title": "Inter-System Closed-Loop Control of Locomotor and Bladder Function in Individuals With Acute Spinal Cord Injury",
"has_exemption": false,
"start_date": "2022-04-04",
"completion_date": "2027-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Claudia Angeli",
"sponsor_slug": "claudia-angeli",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06016855",
"publication_url": "https://clinicaltrials.gov/study/NCT06016855",
"title": "Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2024-05-31",
"completion_date": "2027-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06968845",
"publication_url": "https://clinicaltrials.gov/study/NCT06968845",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Efficacy of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Patients With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2025-05-02",
"completion_date": "2027-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rein Therapeutics",
"sponsor_slug": "rein-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449001",
"publication_url": "https://clinicaltrials.gov/study/NCT06449001",
"title": "A Phase 3 Open-Label Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Clinically Significant Extravascular Hemolysis",
"has_exemption": false,
"start_date": "2025-08-11",
"completion_date": "2027-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209761",
"publication_url": "https://clinicaltrials.gov/study/NCT07209761",
"title": "A Phase 3, Randomized, Open-label, Multicenter Trial to Evaluate the Efficacy, Safety, and Tolerability of 4-month and 6-month Quabodepistat-containing Regimens for Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2027-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05284747",
"publication_url": "https://clinicaltrials.gov/study/NCT05284747",
"title": "EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction",
"has_exemption": false,
"start_date": "2022-10-26",
"completion_date": "2027-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07026877",
"publication_url": "https://clinicaltrials.gov/study/NCT07026877",
"title": "A Prospective, Multicenter, Non-Blinded, Non-Randomized Pivotal Study of the Fenestrated TREO Stent-Graft System in Subjects With Abdominal Aortic Aneurysms Requiring a Fenestrated Graft and Suitable for Endovascular Repair",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2027-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Bolton Medical",
"sponsor_slug": "bolton-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03242642",
"publication_url": "https://clinicaltrials.gov/study/NCT03242642",
"title": "Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial",
"has_exemption": false,
"start_date": "2017-10-23",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiovascular",
"sponsor_slug": "medtronic-cardiovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04910022",
"publication_url": "https://clinicaltrials.gov/study/NCT04910022",
"title": "A Phase I/II Combination Study of NMS-03305293 and Temozolomide in Adult Patients With Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2021-12-01",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nerviano Medical Sciences",
"sponsor_slug": "nerviano-medical-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05786417",
"publication_url": "https://clinicaltrials.gov/study/NCT05786417",
"title": "A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER",
"has_exemption": false,
"start_date": "2023-05-10",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06436612",
"publication_url": "https://clinicaltrials.gov/study/NCT06436612",
"title": "Phase II Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561087",
"publication_url": "https://clinicaltrials.gov/study/NCT06561087",
"title": "Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06476132",
"publication_url": "https://clinicaltrials.gov/study/NCT06476132",
"title": "Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients: A Randomized, Multicenter, Double Blind, Placebo-Controlled Trial (CTOT-47)",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06916286",
"publication_url": "https://clinicaltrials.gov/study/NCT06916286",
"title": "A Prospective, Randomized, Multi-center Trial Evaluating the Effect of Surgical Drain Securement on Patient Quality of Life and Postoperative Drain-related Complications",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06982820",
"publication_url": "https://clinicaltrials.gov/study/NCT06982820",
"title": "A Prospective, Randomized, Double-blind, Controlled Study to Produce Guidelines for Integrating Prism for MDD Therapy (Reward System [RS] Upregulation) and to Demonstrate Its Superiority Over Sham Therapy",
"has_exemption": false,
"start_date": "2025-06-25",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GrayMatters Health Ltd.",
"sponsor_slug": "graymatters-health-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04480619",
"publication_url": "https://clinicaltrials.gov/study/NCT04480619",
"title": "Safety and Efficacy of Ga-68-IAC Positron Emission Tomography (PET/CT) for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients.",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2027-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Advanced Imaging Projects, LLC",
"sponsor_slug": "advanced-imaging-projects-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01864109",
"publication_url": "https://clinicaltrials.gov/study/NCT01864109",
"title": "A Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma",
"has_exemption": false,
"start_date": "2013-05-31",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02656511",
"publication_url": "https://clinicaltrials.gov/study/NCT02656511",
"title": "Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection",
"has_exemption": false,
"start_date": "2015-12-31",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02727803",
"publication_url": "https://clinicaltrials.gov/study/NCT02727803",
"title": "Personalized NK Cell Therapy in CBT",
"has_exemption": false,
"start_date": "2016-05-19",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03128879",
"publication_url": "https://clinicaltrials.gov/study/NCT03128879",
"title": "A Phase II Study of Venetoclax (ABT-199) Consolidation for Patients Currently Receiving Ibrutinib or Acalabrutinib for High-risk CLL",
"has_exemption": false,
"start_date": "2017-06-16",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03110926",
"publication_url": "https://clinicaltrials.gov/study/NCT03110926",
"title": "Induction Chemotherapy for Locally Advanced Esophageal Cancer: A Phase II Study",
"has_exemption": false,
"start_date": "2017-06-19",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03233399",
"publication_url": "https://clinicaltrials.gov/study/NCT03233399",
"title": "Modulating Movement Intention Via Cortical Stimulation in Healthy Subjects and Patients With Psychogenic Movement Disorders and Non-epileptic Seizures",
"has_exemption": false,
"start_date": "2017-07-20",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03384836",
"publication_url": "https://clinicaltrials.gov/study/NCT03384836",
"title": "A Phase Ib/II Study of Propranolol With Fixed-Dose Pembrolizumab in Patients With Unresectable Stage III and Stage IV Melanoma",
"has_exemption": false,
"start_date": "2018-01-31",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03667651",
"publication_url": "https://clinicaltrials.gov/study/NCT03667651",
"title": "THE PEBBLES STUDY: A Randomised Controlled Trial to Prevent Eczema, Food Allergy and Sensitisation Using a Skin Barrier Improvement Strategy",
"has_exemption": false,
"start_date": "2018-03-06",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Melbourne",
"sponsor_slug": "university-of-melbourne",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03898479",
"publication_url": "https://clinicaltrials.gov/study/NCT03898479",
"title": "A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata",
"has_exemption": false,
"start_date": "2019-04-04",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Pharmaceutical Industries, Inc.",
"sponsor_slug": "sun-pharmaceutical-industries-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05999994",
"publication_url": "https://clinicaltrials.gov/study/NCT05999994",
"title": "CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research",
"has_exemption": false,
"start_date": "2020-01-22",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04293185",
"publication_url": "https://clinicaltrials.gov/study/NCT04293185",
"title": "A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the BB305 Lentiviral Vector in Subjects With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2020-02-14",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genetix Biotherapeutics Inc.",
"sponsor_slug": "genetix-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04420702",
"publication_url": "https://clinicaltrials.gov/study/NCT04420702",
"title": "Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer",
"has_exemption": false,
"start_date": "2020-02-27",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04176718",
"publication_url": "https://clinicaltrials.gov/study/NCT04176718",
"title": "A Phase II Study of Daratumumab With Weekly Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-05-18",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Yee, MD",
"sponsor_slug": "andrew-yee-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04322955",
"publication_url": "https://clinicaltrials.gov/study/NCT04322955",
"title": "Cyto-KIK; TRIAL (CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy (Nivolumab) and Targeted Kinase Inhibition (Cabozantinib)",
"has_exemption": false,
"start_date": "2020-06-22",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mark Stein",
"sponsor_slug": "mark-stein",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04485286",
"publication_url": "https://clinicaltrials.gov/study/NCT04485286",
"title": "Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury",
"has_exemption": false,
"start_date": "2020-07-19",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04736173",
"publication_url": "https://clinicaltrials.gov/study/NCT04736173",
"title": "Official Title: A Phase 2 Study to Evaluate Zimberelimab (AB122) Combined With AB154 in Front-Line, PD-L1-High, Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2021-02-08",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04721132",
"publication_url": "https://clinicaltrials.gov/study/NCT04721132",
"title": "An Open-Label, Phase II, Pre-Operative Study of Atezolizumab Plus Bevacizumab for Resectable Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2021-02-10",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04775485",
"publication_url": "https://clinicaltrials.gov/study/NCT04775485",
"title": "FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients With RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors",
"has_exemption": true,
"start_date": "2021-04-22",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Day One Biopharmaceuticals, Inc.",
"sponsor_slug": "day-one-biopharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04957615",
"publication_url": "https://clinicaltrials.gov/study/NCT04957615",
"title": "A Phase II Clinical Trial to Investigate ARID1A Mutation and CXCL13 Expression in the Pre-Treatment Tumor Samples as a Combinatorial Predictive Biomarker for Immune Checkpoint Therapy in Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2021-09-21",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04833140",
"publication_url": "https://clinicaltrials.gov/study/NCT04833140",
"title": "Estrogen Administration for the Treatment of NASH in Postmenopausal Women",
"has_exemption": false,
"start_date": "2021-12-02",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05097287",
"publication_url": "https://clinicaltrials.gov/study/NCT05097287",
"title": "A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma",
"has_exemption": false,
"start_date": "2021-12-16",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04599504",
"publication_url": "https://clinicaltrials.gov/study/NCT04599504",
"title": "Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)",
"has_exemption": false,
"start_date": "2022-01-02",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04605081",
"publication_url": "https://clinicaltrials.gov/study/NCT04605081",
"title": "Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Maintenance Treatment (Stage 2a)",
"has_exemption": false,
"start_date": "2022-01-10",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04380740",
"publication_url": "https://clinicaltrials.gov/study/NCT04380740",
"title": "A Randomized Double-Blind Trial of Abatacept Extended Dosing Versus Abatacept Short-term Dosing for Graft Versus Host Disease Prophylaxis: \"ABA3\"",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05081128",
"publication_url": "https://clinicaltrials.gov/study/NCT05081128",
"title": "A Placebo-Controlled Efficacy in iNPH Shunting (PENS) Trial",
"has_exemption": false,
"start_date": "2022-05-18",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05379985",
"publication_url": "https://clinicaltrials.gov/study/NCT05379985",
"title": "A Multicenter Open-Label Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS",
"has_exemption": false,
"start_date": "2022-05-31",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03828201",
"publication_url": "https://clinicaltrials.gov/study/NCT03828201",
"title": "Prospective, Randomized, Partially Blinded, Phase 2 Study of the Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine for Treatment of Patients With MDR-TB",
"has_exemption": false,
"start_date": "2022-06-07",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston University",
"sponsor_slug": "boston-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05429632",
"publication_url": "https://clinicaltrials.gov/study/NCT05429632",
"title": "Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT",
"has_exemption": false,
"start_date": "2022-06-16",
"completion_date": "2027-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Priothera SAS",
"sponsor_slug": "priothera-sas",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}